Genetic instability and diminished differentiation capacity in long-term cultured mouse neurosphere cells.
The potential use of neural stem cells in basic research, drug testing and for development of therapeutic strategies requires large scale in vitro amplification, increasing the probability of genetic instability and transformation. Little is known, however, about potential correlations between long-term culture of neural stem and progenitor cells (NSPCs), changed differentiation and self-renewal capacities, and the occurrence of chromosomal instability. This study investigates the effect of extended culture time on self-renewal, differentiation capacity, cell cycle phase distribution, telomere length, telomerase activity and chromosomal stability on fetal brain-derived cells that form floating sphere colonies (neurospheres). We observed that increased sphere-forming capacity indicative of increased proliferation was accompanied by a decreased ability to differentiate into neural lineages. The high mobility group A (Hmga2) gene positively regulates self-renewal via repression of p16(Ink4a) and p19(ARF) gene expression. This study discerned an upregulation of Hmga2 gene and protein expression and decreased p16(Ink4a) and p19(ARF) gene expression, suggesting that Hmga2 might promote the proliferation of neurosphere cells in long-term culture. Further, our analyses revealed a significant decrease in telomere length after 4 weeks of culturing that is paralleled by a moderate upregulation of telomerase activity. Importantly, regular gain of chromosome 1 with random structural chromosomal aberrations was observed within 16 weeks of neurosphere cell culture. Genetic instability and diminished differentiation capacity seem to be a consequence of long-term culture of neurosphere cells. These data indicate the necessity to analyze self-renewal, differentiation capacity, telomere length, tumor suppressor genes and chromosomal stability in neurosphere cultures prior to their usage in basic research, drug testing or the development of therapeutic strategies.
Vukicevic
Vladimir
V
Molecular Endocrinology, MKIII, University Clinic Dresden, Fiedlerstr. 42, 01307 Dresden, Germany. vladimir.vukicevic@uniklinikum-dresden.de
Jauch
Anna
A
Dinger
Timo C
TC
Gebauer
Linda
L
Hornich
Veronika
V
Bornstein
Stefan R
SR
Ehrhart-Bornstein
Monika
M
Müller
Albrecht M
AM
D000818:Animals; D001921:Brain / Q000378:metabolism; D002453:Cell Cycle / Q000235:genetics*; D002454:Cell Differentiation / Q000235:genetics*; D002478:Cells, Cultured; D004622:Embryo, Mammalian / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D039902:Multipotent Stem Cells / Q000378:metabolism*; D009420:Nervous System / Q000196:embryology / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism*; D018874:Spheroids, Cellular / Q000378:metabolism; D013997:Time Factors